Although investing in unprofitable companies can be profitable, it's important to consider cash burn risks. Anixa Biosciences, with a 3.2-year cash runway, shows promising financial management despite increasing cash burn. Investors should monitor its growth trajectory and potential fundraising options.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing